Epidemiology and prevention of respiratory syncytial virus infections among infants and young children.
about
Respiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: Systematic Review.Challenges and opportunities in developing respiratory syncytial virus therapeuticsThe impact of influenza and respiratory syncytial virus on hospitalizations for lower respiratory tract infections in young children: Slovenia, 2006-2011.Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infantsRespiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.A multi-laboratory study of diverse RSV neutralization assays indicates feasibility for harmonization with an international standard.Molecular epidemiology of respiratory syncytial virus transmission in childcareA prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation.Respiratory syncytial virus-associated hospitalizations in pre-mature infants in Lima, PeruRespiratory syncytial virus-associated mortality in hospitalized infants and young children.Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States.Surveillance for hospitalized acute respiratory infection in Guatemala.Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012.Viral acute lower respiratory infections impair CD8+ T cells through PD-1A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS).Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses.(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection.Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study.Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registriesImmunogenicity of RSV F DNA Vaccine in BALB/c Mice.Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.Predictors of severity and mortality in children hospitalized with respiratory syncytial virus infection in a tropical region.Respiratory syncytial virus persistence in macrophages alters the profile of cellular gene expression.Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.Effectiveness of Palivizumab in High-risk Infants and Children: A Propensity Score Weighted Regression Analysis.Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation.Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32-35 Weeks Gestational Age.Respiratory syncytial virus, adenoviruses, and mixed acute lower respiratory infections in children in a developing country.Respiratory Syncytial Virus Infection Changes Cargo Composition of Exosome Released from Airway Epithelial Cells.
P2860
Q30251560-D222B532-99D1-4838-AF0F-9EAFE54BFBE1Q30300567-CD394D0E-54B2-470B-9E4D-A7A8BFD75D4CQ30432137-619FD54A-06A0-4A37-B38E-F043CB1BB29CQ31047460-FFEAA804-758A-492A-95A6-8F772BE6AD23Q33630047-E392B2FD-E908-4C72-B142-669E4578D2BAQ33712575-8C74C25A-7805-4615-9132-17B506C0AFC2Q34345345-AED1312F-BDF2-438F-B192-C99C3875D148Q34401644-FEF63E52-F746-4DC8-82B7-E654D06CD7F7Q34496098-5244B703-83D5-405A-8044-BCC0E08F002CQ34785440-2EB4029D-AB7A-4C9B-91DD-8357566C3E17Q34876356-A625CB94-413F-43A9-840A-7F9AB6E44993Q35082538-39148DCB-2C59-458C-8231-E57C4EA177B2Q35980935-3C2A1FF8-D0CF-40D7-AFDE-C5DE132ADC8AQ36129102-0A656714-99BC-4BAD-AEE9-F0196743CA58Q36275397-8C259D99-B484-4549-ADFF-E786EBDFEA9BQ36295566-40EF4CFC-7F7B-4B5D-87DB-C4273C833DE8Q36422466-AE26E7CC-379F-48A7-8F9F-6D310A9D3CB0Q36676407-12F4305A-92C6-4D0B-BBB4-387099BEBE6AQ36989863-377DFB27-6D7D-4807-8FB2-0C85A56A2BEBQ37263840-D840629C-7787-475F-BF74-101E01D34788Q37591891-D2D95283-E012-48B8-ADF1-242312FA15C4Q37727985-E7DAA4BB-6B92-4571-B07E-4F676DF448DBQ38076133-FDCA9D6C-9F07-4BAE-A649-2073C6B94CBFQ40043100-EB03B009-B930-4AD6-BEFA-71D5CCBBE26AQ40043300-D946A6D0-4912-4638-BB7C-6D938FD701E4Q40122511-A0CB8376-1CF8-4281-AC3D-A158E33786EAQ40244825-E37EF129-60FD-45C2-BA76-4E4CFD68B411Q40516621-8D01988F-58EB-4EC9-BFB7-0D3526F8A0D2Q41138647-C2FD3665-6976-41D1-ABF8-62377ADC436CQ47555719-9B2D9736-9579-4373-81CB-6A0870EB4042
P2860
Epidemiology and prevention of respiratory syncytial virus infections among infants and young children.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiology and prevention of ...... ng infants and young children.
@en
Epidemiology and prevention of ...... ng infants and young children.
@nl
type
label
Epidemiology and prevention of ...... ng infants and young children.
@en
Epidemiology and prevention of ...... ng infants and young children.
@nl
prefLabel
Epidemiology and prevention of ...... ng infants and young children.
@en
Epidemiology and prevention of ...... ng infants and young children.
@nl
P1476
Epidemiology and prevention of ...... ng infants and young children.
@en
P2093
Gayle Fischer Langley
Larry J Anderson
P304
P356
10.1097/INF.0B013E3182184AE7
P577
2011-06-01T00:00:00Z